Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease.
Baldus S, Köster R, Chumley P, Heitzer T, Rudolph V, Ostad MA, Warnholtz A, Staude HJ, Thuneke F, Koss K, Berger J, Meinertz T, Freeman BA, Münzel T. Baldus S, et al. Among authors: warnholtz a. Free Radic Biol Med. 2005 Nov 1;39(9):1184-90. doi: 10.1016/j.freeradbiomed.2005.06.004. Epub 2005 Aug 10. Free Radic Biol Med. 2005. PMID: 16214034 Free PMC article. Clinical Trial.
Why do antioxidants fail to provide clinical benefit?
Warnholtz A, Münzel T. Warnholtz A, et al. Curr Control Trials Cardiovasc Med. 2000;1(1):38-40. doi: 10.1186/cvm-1-1-038. Curr Control Trials Cardiovasc Med. 2000. PMID: 11714406 Free PMC article.
Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits.
Warnholtz A, Mollnau H, Heitzer T, Kontush A, Möller-Bertram T, Lavall D, Giaid A, Beisiegel U, Marklund SL, Walter U, Meinertz T, Munzel T. Warnholtz A, et al. J Am Coll Cardiol. 2002 Oct 2;40(7):1356-63. doi: 10.1016/s0735-1097(02)02133-2. J Am Coll Cardiol. 2002. PMID: 12383586 Free article.
Effects of oral niacin on endothelial dysfunction in patients with coronary artery disease: results of the randomized, double-blind, placebo-controlled INEF study.
Warnholtz A, Wild P, Ostad MA, Elsner V, Stieber F, Schinzel R, Walter U, Peetz D, Lackner K, Blankenberg S, Munzel T. Warnholtz A, et al. Atherosclerosis. 2009 May;204(1):216-21. doi: 10.1016/j.atherosclerosis.2008.08.003. Epub 2008 Aug 12. Atherosclerosis. 2009. PMID: 18822413 Clinical Trial.
Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.
Ostad MA, Eggeling S, Tschentscher P, Schwedhelm E, Böger R, Wenzel P, Meinertz T, Munzel T, Warnholtz A. Ostad MA, et al. Among authors: warnholtz a. Atherosclerosis. 2009 Jul;205(1):227-32. doi: 10.1016/j.atherosclerosis.2008.11.032. Epub 2008 Dec 9. Atherosclerosis. 2009. PMID: 19150064 Clinical Trial.
56 results